Literature DB >> 11405552

Increased urinary nitrite, a marker of nitric oxide, in active inflammatory bowel disease.

M G Goggins1, S A Shah, J Goh, A Cherukuri, D G Weir, D Kelleher, N Mahmud.   

Abstract

BACKGROUND: Nitric oxide (NO) production is increased in inflammatory bowel disease (IBD), and measurement of NO metabolites may be useful for monitoring disease activity. AIMS AND
OBJECTIVES: To characterise urinary nitrite levels, a stable metabolite of NO, in IBD and to evaluate its potential as a marker of disease activity.
METHODS: Twelve-hour urinary nitrites were measured by the microplate assay method in 46 patients with IBD (active; n = 32). Urinary samples from 16 healthy individuals served as controls.
RESULTS: Increased levels of urinary nitrites were found in patients with active IBD compared with those with inactive IBD. Twenty-eight out of 32 patients (87.5%) with active IBD had detectable levels of nitrite in their urine as compared with 2/14 (14.3%) patients with inactive IBD. None of the 16 healthy controls had detectable urinary nitrite. Twelve-hour urinary nitrite in active compared with inactive IBD: 5 0.7 versus 0.1+/-0.04 micromol (P < 0.05). There was good correlation between urinary nitrite and some markers of disease activity in IBD such as C-reactive protein and microalbuminuria but not with erythrocyte sedimentation rate.
CONCLUSIONS: Increased levels of nitrite were detected in urine of patients with active IBD, consistent with increased NO synthesis. This simple assay may be exploited as a potential marker of disease activity in IBD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11405552      PMCID: PMC1781692          DOI: 10.1080/09629350120054536

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  36 in total

Review 1.  Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Biochem Pharmacol       Date:  1989-06-01       Impact factor: 5.858

2.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

Authors:  L J Ignarro; G M Buga; K S Wood; R E Byrns; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats.

Authors:  X Guo; W P Wang; J K Ko; C H Cho
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

4.  Detectable colonic nitrite levels in inflammatory bowel disease--mucosal or bacterial malfunction?

Authors:  W E Roediger; M J Lawson; S H Nance; B C Radcliffe
Journal:  Digestion       Date:  1986       Impact factor: 3.216

5.  A simple index of Crohn's-disease activity.

Authors:  R F Harvey; J M Bradshaw
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

6.  Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion.

Authors:  D G Binion; P Rafiee; K S Ramanujam; S Fu; P J Fisher; M T Rivera; C P Johnson; M F Otterson; G L Telford; K T Wilson
Journal:  Free Radic Biol Med       Date:  2000-11-01       Impact factor: 7.376

7.  Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis.

Authors:  J T Green; C Richardson; R W Marshall; J Rhodes; H C McKirdy; G A Thomas; G T Williams
Journal:  Aliment Pharmacol Ther       Date:  2000-11       Impact factor: 8.171

8.  Inhibition of inducible nitric oxide synthase in the human intestinal epithelial cell line, DLD-1, by the inducers of heme oxygenase 1, bismuth salts, heme, and nitric oxide donors.

Authors:  M Cavicchi; L Gibbs; B J Whittle
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 9.  Nitric oxide and intestinal inflammation.

Authors:  P Kubes; D M McCafferty
Journal:  Am J Med       Date:  2000-08-01       Impact factor: 4.965

10.  Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion.

Authors:  T B McCall; N K Boughton-Smith; R M Palmer; B J Whittle; S Moncada
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

View more
  7 in total

Review 1.  Immunostimulation in the era of the metagenome.

Authors:  Amy D Proal; Paul J Albert; Greg P Blaney; Inge A Lindseth; Chris Benediktsson; Trevor G Marshall
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Nitric oxide and superoxide in rat mesangial cells: modulation by C-reactive protein.

Authors:  Howard Trachtman; Stephen Futterweit; Christopher Arzberger; Jessica Bod; Judah Goldschmiedt; Haddassah Gorman; Krishna Reddy; Nicholas Franki; Pravin C Singhal
Journal:  Pediatr Nephrol       Date:  2006-03-25       Impact factor: 3.714

Review 3.  The role of oral bacteria in inflammatory bowel disease.

Authors:  Emily Read; Michael A Curtis; Joana F Neves
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-08-16       Impact factor: 46.802

4.  Nitric oxide as a potential biomarker in inflammatory bowel disease.

Authors:  Nesina Avdagić; Asija Zaćiragić; Nermina Babić; Mirsada Hukić; Mensura Seremet; Orhan Lepara; Emina Nakaš-Ićindić
Journal:  Bosn J Basic Med Sci       Date:  2013-02       Impact factor: 3.363

5.  Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis.

Authors:  John Leung; Ann Nguyen-Traxler; Erika M Lee; Jason S Yip; Joel V Weinstock; Walter W Chan; Peter Ngo; Barbara J Weinstein; Peter A Bonis
Journal:  Allergy Asthma Proc       Date:  2012 Nov-Dec       Impact factor: 2.587

6.  Poor Relationship Between Fractionated Exhaled Nitric Oxide and Disease Activity in Eosinophilic Esophagitis.

Authors:  Kimberly Johnson; Vivek Iyer; David Katzka; Karthik Ravi; Ryan Lennon; Richard Pendegraft; Debra Geno; Jeffrey Alexander
Journal:  Dysphagia       Date:  2018-07-24       Impact factor: 3.438

7.  Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases.

Authors:  Golshid Jahanshahi; Vian Motavasel; Ali Rezaie; Ali A Hashtroudi; Naser E Daryani; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.487

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.